DataMSA Survey Representing Individuals Lost to MSA (Multiple System Atrophy)

The purpose of this survey was to collect data and information from individuals who are currently living with Multiple System Atrophy (MSA), and from caregivers and loved ones of those lost to MSA.

The data collected through this survey was made available, at no cost, to groups, agencies and medical personnel providing treatment, education and research for MSA.

IMPORTANT:
– Please do not respond to this survey if the individual has/had not received a formal diagnosis of MSA.
– Please respond ONLY ONCE per individual living with or lost to MSA.
– All respondents will remain confidential.

who is completing this survey
Person living with MSA318
Caregiver/loved one of an individual currently living with MSA388
Caregiver/loved one of an individual lost to MSA123

Background Information:

In which country/region does/did the individual reside? 829 responses

Regionresponses
Region I: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont39
Region II: New Jersey, New York, Puerto Rico, Virgin Islands40
Region III: Delaware, District of Columbia, Maryland, Pennsylvania, Virginia, West Virginia50
Region IV: Alabama, Florida, Georgia, Kentucky, Mississippi, North Carolina, South Carolina, Tennessee106
Region V: Illinois, Indiana, Michigan, Minnesota, Ohio, Wisconsin98
Region VI: Arkansas, Louisiana, New Mexico, Oklahoma, Texas76
Region VII: Iowa, Kansas, Missouri, Nebraska31
Region VIII: Colorado, Montana, North Dakota, South Dakota, Utah, Wyoming14
Region IX: Arizona, California, Hawaii, Nevada (American Samoa, Guam, Northern Mariana Islands, Trust Territory of the Pacific Islands)53
Region X: Alaska, Idaho, Oregon, Washington48
Region XI: Canada38
Region XII: Central America2
Region XIII: Asia15
Region XIV: Africa13
Region XV: South America1
Region XVI: Antarctica1
Region XVII: Europe86
Region XVIII: Australia (continent), New Zealand72
Region XVIII: Australia (continent)30
Region I: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermon16

What is/was the individual’s gender? 829 responses

GenderResponses
male486
female343

Diagnosis Data:

At what age was the individual diagnosed with MSA? 829 responses

Age at diagnosisResponses
20-250
26-301
31-353
36-4011
41-4528
46-5075
51-55158
56-60179
61-65180
66-70106
71-7563
76-8016
80 or older9

With which type of MSA was the individual diagnosed? 829 responses

Type of multiple system atrophyresonses
MSAc364
MSAp237
uncertain228

How long did it take for the individual to secure a Probable/likely diagnosis of MSA? 823 responses

Time to secure Probable/likely MSA diagnosisresponses
0-6 months98
6-12 months129
12-18 months137
18-24 months110
24 or more months349

How many neurologists did the individual consult during the diagnosis process? 826 responses

number of neurologistsresponses
1116
2264
3244
4122
5 or more77
I have not been seen by a neurologist3

Was the individual diagnosed with any condition(s)/illness(es) prior to receiving a diagnosis of MSA? 820 responses

other diagnosisresponses
no231
yes589

At what age did the individual first notice symptoms, later attributed to MSA? 824 responses

age at first Symptomsresponses
20-253
26-304
31-359
36-4025
41-4562
46-50135
51-55174
56-60187
61-65130
66-7065
71-7523
76-805
80 or older2

Please indicate events which cause/caused the individual’s MSA symptoms to worsen? 798 responses

Are/Were any cycles observed with regard to periods of worsening of the individual’s symptoms? 774 responsesn

yes/noRespondents
no500
yes274

If cycles are/were observed with regard to worsening of the individual’s symptoms, on average, what was the frequency of the cycles? 319

FrequencyRespondents
approximately twice a week76
approximately once a week67
approximately twice a month47
approximately once a month66
less frequently than once a month63

If cycles are/were observed with regard to worsening of the individual’s symptoms, what was the duration of the cycle? 307

DurationRespondents
less than 6 hours44
6-12 hours38
13-18 hours8
19-24 hours15
one to two days81
more than two full days121

Are/Were there any strategies/interventions that help(ed) reduce the individual’s symptoms? 710 responses

yes/norespondents
no313
yes397

If yes, what are/were the strategies/interventions that help(ed) reduce the individual’s symptoms? 420 responses

Strategy/interventionrespondents
Diet144
Exercise/Physical Activity246
Physical Therapy/ Movement Therapy260
Accupuncture27
Light Therapy14
Speech Therapy172
Supplements (please describe below)71
Socialization129
Games, Puzzles, etc.75

Neurological Care:

On average, what is/was the frequency of the individual’s neurological care? 814 responses

frequencyrespondents
less than once a year61
once a year69
twice a year236
three or more times a year391
no neurological care since diagnosis57

Has/Had the individual participated in clinical research regarding MSA? 810 responses

yes/norespondents
no717
yes93

In the past/last year, how would you describe the rate of progression of the individual’s MSA illness? 793 responses

Rate of progressionrespondents
(1) very few signs of any progression in the past/last year21
(2) some subtle signs of progression in the past/last year77
(3) definite signs of progression in the past/last year389
(4) rapid progression in the past/last year306

Living Conditions:

Does/Did the individual receive adequate support to live comfortably? 775 responses

yes/norespondents
yes695
no80

If the individual was lost to MSA, how long after MSA diagnosis did he/she live? 133 responses

one year5
two years13
three years33
four years17
five years14
six years6
seven years5
eight years5
nine years7
ten years7
Still living2
9 months2

If the individual was lost to MSA, please indicate the cause of death: 123 blockage1/511.4%26.8%30.9%

Cause of deathRespondents
Respiratory failure (stopped breathing)38
Respiratory infection (e.g.: pneumonia)33
Respiratory blockage (choking, obstruction)7
Heart attack1
Stroke2
Other complications from blood clot(s)2
Digestive system failure (unable to digest food)2
Digestive system blockage14
Head injury due to fall0
Other injury due to fall0

If the individual was lost to MSA, what was his/her age at the time of death? 131 responses

Age at time of deathrespondents
20-250
26-300
31-353
36-401
41-450
46-504
51-557
56-6019
61-6536
66-7030
71-7522
76-806
81-851
86-901
90 or older1

Has/Had the individual made arrangements to donate his/her brain to an agency for Research? 654 response

yes/norespondents
No525
Yes129

Does/Did the individual with MSA support a “patient’s right to die?” 719 responses

yes/norespondents
no72
yes420
uncertain/undecided227

Thank you for taking the time to complete this survey – your input is invaluable for those involved in MSA research, education and awareness.

Ciarán Walsh

Research Assistant

Sensors, Data cleaning, Field logistics

Daniel Okeke

MSc Student

Environmental justice, Interviews, Mapping

PhD Researcher

Water access, Community research, GIS

Amina El-Khoury

Postdoctoral Fellow

Coastal change, Risk, Mixed methods

Visiting Collaborators

Network

Partnerships, Coauthorship, Shared datasets

F.A.Q.

What’s the difference between Field Notes and Publications?

Field Notes are working-facing posts—method notes, reflections, and updates written for readability and practical reuse. Publications are formal research outputs (journal articles, reports, and working papers) with citation details and official links.

Can I reuse your datasets, protocols, or templates?

Often, yes. Each resource lists its license and any access conditions. If a dataset is restricted (e.g., sensitive locations or participant privacy), we’ll note how to request access.

How should I cite something from this site?

Use the citation information on the relevant page when available (publication citation, dataset version, or post date).

When in doubt, cite the page title, NotesLab®, the year, and the URL.

How do I collaborate or request access to restricted materials?

Email noteslab@dier.ie with a short description of your project and what you need (e.g., dataset version, intended use, timeline). We typically respond within 3–5 working days.